Rein Therapeutics, Inc. · NASDAQ:RNTX

Rein Therapeutics, Inc. shareholders

As of Sep 30, 2026, 62 institutions reported holding Rein Therapeutics, Inc., 47.7% of its shares. Largest: Voss Capital, LP, Cable Car Capital, LP and ADAR1 Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Rein Therapeutics, Inc.ChangeFiled
Voss Capital, LP5.85M6.8%+588KNov 16, 2026
Cable Car Capital, LP5.2M6.0%no changeNov 16, 2026
ADAR1 Capital Management, LLC4.5M5.2%no changeNov 16, 2026
Vanguard3.9M4.5%+123KNov 13, 2026
BIOS Capital Management, LP2.98M3.5%no changeNov 13, 2026
Ikarian Capital, LLC2.95M3.4%no changeNov 16, 2026
Citadel2.57M3.0%+128KNov 16, 2026
Velan Capital Investment Management LP1.7M2.0%no changeNov 16, 2026
Great Point Partners LLC1.66M1.9%−912KNov 16, 2026
Prosight Management, LP1.66M1.9%+560KNov 13, 2026

Rein Therapeutics, Inc. insider trades